SCHEMBL18739734

SCHEMBL18739734

Brc1cncc2ncc(N3CCOCC3)nc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ MAPK1 P28482 4/20 0.40
▸ ABL1 P00519 2/20 0.40
▸ NTRK1 P04629 2/20 0.40
▸ YES1 P07947 2/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ KDR P35968 2/20 0.40
▸ HIPK1 Q86Z02 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ HPGD P15428 4/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HTT P42858 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18739760 0.81 KMT2A (0.46) ALDH1A1MAPK1TSHRHPGDHSD17B10
SCHEMBL30808213 0.79 MET (0.46) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL18739629 0.79 MET (0.47) ALDH1A1MAPK1TSHRHPGDHSD17B10
SCHEMBL30808177 0.79 MET (0.47) ALDH1A1MAPK1TSHRHPGDHSD17B10
SCHEMBL27191790 0.78 CCNC (0.54) ALDH1A1MAPK1HPGDHSD17B10KDM4E
SCHEMBL18739157 0.77 PIK3CD (0.41) ALDH1A1MAPK1ABL1NTRK1YES1
SCHEMBL18739511 0.77 PIK3CA (0.39) MAPK1ABL1NTRK1YES1PIM1
SCHEMBL18739542 0.77 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10KDM4EMAPT
SCHEMBL23028473 0.76 CNR2 (0.42) ALDH1A1MAPK1KDM4EGAAMAPT
SCHEMBL19725176 0.76 CXCR4 (0.44) ALDH1A1TSHRHPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3359533-B1 QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-11-17 — — EP disclosed
WO-2017060406-A1 QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2017-04-13 — — WO disclosed
Send feedback